Search

for
Search:

Sort by

Research

990-1000 / 1000+ results

Efficacy and Safety of Once-Daily Minoxidil Foam 5% Versus Twice-Daily Minoxidil Solution 2% in Female Pattern Hair Loss: A Phase III, Randomized, Investigator-Blinded Study

research Faculty Opinions recommendation of Efficacy and Safety of Once-Daily Minoxidil Foam 5% Versus Twice-Daily Minoxidil Solution 2% in Female Pattern Hair Loss: A Phase III, Randomized, Investigator-Blinded Study.

September 2016 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature”

Once-daily 5% minoxidil foam increases hair regrowth and density in women with hair loss, but not as effectively as twice-daily 2% minoxidil solution, though it's safer and more convenient.

research Hypertrichosis of the malar areas and poliosis of the eyelashes caused by latanoprost

5 citations , July 2014 in “Actas dermo-sifiliográficas/Actas dermo-sifiliográficas”

Latanoprost eye drops caused excessive hair growth and eyelash whitening in a woman.

research Finasteride plus doxazosin combination tops in BPH

August 2002 in “Inpharma Weekly”

Hair Regenerative Effect of Silk Fibroin Hydrogel with Incorporation of FGF-2-Liposome and Its Potential Mechanism in Mice with Testosterone-Induced Alopecia Areata

research Hair regenerative effect of silk fibroin hydrogel with incorporation of FGF-2-liposome and its potential mechanism in mice with testosterone-induced alopecia areata

12 citations , September 2018 in “Journal of Drug Delivery Science and Technology”

The silk fibroin hydrogel with FGF-2-liposome can potentially treat hair loss in mice.

research Hand-Foot and Stump Syndrome to Sorafenib

45 citations , January 2007 in “Journal of Clinical Oncology”

Sorafenib may cause hand-foot and stump syndrome, requiring early detection and management.

research The effectiveness of adding low-level light therapy to minoxidil 5% solution in the treatment of patients with androgenetic alopecia

14 citations , January 2018 in “Indian Journal of Dermatology, Venereology and Leprology”

Adding low-level light therapy to minoxidil improves hair growth and patient satisfaction.

research Low dose oral minoxidil for the treatment of female pattern hair loss

August 2024 in “Skin Research and Technology”

Low-dose oral minoxidil can help increase hair growth in women with hair loss.

Various Applications of Tofacitinib and Ruxolitinib in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective

research Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective

8 citations , October 2022 in “Dermatology practical & conceptual”

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Comparative Efficacy of 2% Minoxidil Alone Versus Combination With Low-Level Laser Therapy in Female Pattern Hair Loss: A Randomized Controlled Trial in Chinese Females

research Comparative Efficacy of 2% Minoxidil Alone Against Combination of 2% Minoxidil and Low-level Laser therapy in Female Pattern Hair Loss-A Randomized Controlled Trial in Chinese females

January 2024 in “Photodiagnosis and Photodynamic Therapy”

Using minoxidil with laser therapy is more effective for female hair loss than minoxidil alone.

Clinical and Trichoscopic Evaluations of Topical Finasteride 1%, Topical Spironolactone 5%, and Minoxidil 5% in Female Pattern Hair Loss Treatment

research Clinical and Trichoscopic Evaluations of Topical Finasteride 1%, Topical Spironolactone 5%, and Minoxidil 5% in Female Pattern Hair Loss Treatment

January 2025 in “Dermatology Practical & Conceptual”

Topical finasteride is as effective and safe as minoxidil for treating female pattern hair loss.

← Previous page